BCMLT
NMTR

Beacon Capital Management LLC (Tennessee)’s 9 Meters Biopharma NMTR Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-155
Closed -$104 – 1052
2023
Q3 		$104 Hold
155
– – ﹤0.01% 1008
2023
Q2 		$104 Hold
155
– – ﹤0.01% 1008
2023
Q1 		$215 Hold
155
– – ﹤0.01% 915
2022
Q4 		$195 Buy
155
+2
+1% +$5 ﹤0.01% 970
2022
Q3 		$1K Hold
153
– – ﹤0.01% 865
2022
Q2 		$2K Hold
153
– – ﹤0.01% 825
2022
Q1 		$2K Buy
+153
New +$2.09K ﹤0.01% 825

Beacon Capital Management LLC (Tennessee)'s NMTR Position: Q4 2023 in Review

Beacon Capital Management LLC (Tennessee) sold out of 9 Meters Biopharma (NMTR) in Q4 2023, closing a stake of 155 shares — an estimated $104 sold.

Beacon Capital Management LLC (Tennessee) first reported a position in NMTR in Q1 2022 and held it in 7 quarters. The position peaked at $2K in Q2 2022. 1 fund tracked by Wall St. Rank holds NMTR as of Q4 2023.

  • Beacon Capital Management LLC (Tennessee) reported no remaining 9 Meters Biopharma position as of Q4 2023 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 155 9 Meters Biopharma shares in Q4 2023, an estimated $104.
  • Beacon Capital Management LLC (Tennessee) first reported a position in 9 Meters Biopharma in Q1 2022 and held it in 7 quarters.
  • Beacon Capital Management LLC (Tennessee)'s 9 Meters Biopharma position peaked at $2K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2023.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q4 2023, filed 9 Jan 2024.